A new era in Alzheimer's disease management – are we ready?
The availability of new diagnostics and new amyloid-targeting therapies as well as the shift in approach from symptom management to targeting disease pathology mark a truly new era in Alzheimer’s disease (AD) management, according to Professor Jeffrey Burns of the Alzheimer's Disease Research Centre, The University of Kansas, Kansas, US, who spoke at the 29th Hong Kong Medical Forum.